RetractedTrialThe Lancet. Oncology2022

Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study.

Reinhard Dummer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.